BNGO
Price
$1.18
Change
-$0.07 (-5.60%)
Updated
Oct 22 closing price
Capitalization
13.9M
21 days until earnings call
Intraday BUY SELL Signals
ICCM
Price
$1.00
Change
-$0.08 (-7.41%)
Updated
Oct 22 closing price
Capitalization
4.64M
27 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BNGO vs ICCM

BNGO vs ICCM Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BNGO vs. ICCM commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BNGO is a Hold and ICCM is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for BNGO with price predictions
Oct 22, 2026

BNGO sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for BNGO moved above the 200-day moving average on September 28, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for BNGO's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 14 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +2.46% 3-day Advance, the price is estimated to grow further. Considering data from situations where BNGO advanced for three days, in 165 of 214 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BNGO as a result. In 76 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.

The Moving Average Convergence Divergence Histogram (MACD) for BNGO turned negative on September 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 40 similar instances when the indicator turned negative. In 40 of the 40 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

BNGO moved below its 50-day moving average on October 16, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for BNGO crossed bearishly below the 50-day moving average on October 19, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 67%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BNGO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.

The Aroon Indicator for BNGO entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 30 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.440) is normal, around the industry mean (4.961). P/E Ratio (-0.392) is within average values for comparable stocks, (37.232). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (0.481) is also within normal values, averaging (56.876).

The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating fairly steady price growth. BNGO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BNGO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

A.I.Advisor
a Summary for ICCM with price predictions
Oct 22, 2026

ICCM's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for ICCM turned positive on October 19, 2026. Looking at past instances where ICCM's MACD turned positive, the stock continued to rise in 40 of 49 cases over the following month. The odds of a continued upward trend are 82%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 49 of 66 cases where ICCM's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 74%.

Following a +3.85% 3-day Advance, the price is estimated to grow further. Considering data from situations where ICCM advanced for three days, in 161 of 208 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.

ICCM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ICCM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.

The Aroon Indicator for ICCM entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 47 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.390) is normal, around the industry mean (2.874). P/E Ratio (-0.147) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (1.297) is also within normal values, averaging (40.124).

The Tickeron Price Growth Rating for this company is 96 (best 1 - 100 worst), indicating slightly worse than average price growth. ICCM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ICCM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

FUNDAMENTALS RATINGS
BNGO vs ICCM: Fundamental Ratings
BNGO
ICCM
OUTLOOK RATING
1..100
63
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
47
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
6496
P/E GROWTH RATING
1..100
1007
SEASONALITY SCORE
1..100
n/a17

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BNGO's Valuation (30) in the Biotechnology industry is in the same range as ICCM (47) in the null industry. This means that BNGO’s stock grew similarly to ICCM’s over the last 12 months.

BNGO's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ICCM (100) in the null industry. This means that BNGO’s stock grew similarly to ICCM’s over the last 12 months.

BNGO's SMR Rating (98) in the Biotechnology industry is in the same range as ICCM (100) in the null industry. This means that BNGO’s stock grew similarly to ICCM’s over the last 12 months.

BNGO's Price Growth Rating (64) in the Biotechnology industry is in the same range as ICCM (96) in the null industry. This means that BNGO’s stock grew similarly to ICCM’s over the last 12 months.

ICCM's P/E Growth Rating (7) in the null industry is significantly better than the same rating for BNGO (100) in the Biotechnology industry. This means that ICCM’s stock grew significantly faster than BNGO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BNGOICCM
RSI
ODDS (%)
Bullish Trend 1 day ago
74%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
74%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 4 days ago
77%
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 11 days ago
88%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
76%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (BNGO: $1.18 vs. ICCM: $1.08)
Brand notoriety: BNGO and ICCM are both not notable
BNGO represents the Pharmaceuticals: Other, while ICCM is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: BNGO: 37% vs. ICCM: 87%
Market capitalization -- BNGO: $13.9M vs. ICCM: $4.64M
BNGO [@Pharmaceuticals: Other] is valued at $13.9M. ICCM’s [@Medical/Nursing Services] market capitalization is $4.64M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $156.8B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $173.92B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $9.45B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BNGO’s FA Score shows that 1 FA rating(s) are green while ICCM’s FA Score has 1 green FA rating(s).

  • BNGO’s FA Score: 1 green, 4 red.
  • ICCM’s FA Score: 1 green, 4 red.
According to our system of comparison, ICCM is a better buy in the long-term than BNGO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BNGO’s TA Score shows that 4 TA indicator(s) are bullish while ICCM’s TA Score has 4 bullish TA indicator(s).

  • BNGO’s TA Score: 4 bullish, 6 bearish.
  • ICCM’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, ICCM is a better buy in the short-term than BNGO.

Price Growth

BNGO (@Pharmaceuticals: Other) experienced а -13.87% price change this week, while ICCM (@Medical/Nursing Services) price change was +3.85% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.59%. For the same industry, the average monthly price growth was -3.91%, and the average quarterly price growth was +7.47%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.62%. For the same industry, the average monthly price growth was -10.72%, and the average quarterly price growth was -10.29%.

Reported Earning Dates

BNGO is expected to report earnings on Nov 12, 2026.

ICCM is expected to report earnings on Nov 18, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (+0.59% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (-1.62% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
BNGO
Daily Signal:
Gain/Loss:
ICCM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

ICCM and

Correlation & Price change

A.I.dvisor indicates that over the last year, ICCM has been closely correlated with SINT. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if ICCM jumps, then SINT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ICCM
1D Price
Change %
ICCM100%
-7.41%
SINT - ICCM
67%
Closely correlated
-4.07%
ILMN - ICCM
31%
Poorly correlated
-4.76%
PEN - ICCM
31%
Poorly correlated
+0.43%
BRKR - ICCM
29%
Poorly correlated
-3.04%
BNGO - ICCM
29%
Poorly correlated
-5.60%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OPTT0.650.04
+6.93%
Ocean Power Technologies Inc
CLMB31.950.62
+1.98%
Climb Global Solutions Inc
SHAK67.880.04
+0.06%
Shake Shack
LSCC96.40-11.39
-10.57%
Lattice Semiconductor Corp
MRLN0.83-0.15
-15.27%
Merlin Inc